Track which hedge funds hold CRINETICS PHARMACEUTICALS IN and how their positions changed over time.
Current Holders
124
Showing
5
| $665.4M |
| 0.0% |
32 |
| VANGUARD GROUP INC | 2025-Q4 | Decreased | 9.1M | -0.4% | $425.3M | 0.0% | 0 |
| WELLINGTON MANAGEMENT GROUP LLP | 2025-Q4 | Decreased | 8M | -4.1% | $374.2M | 0.1% | 0 |
| BlackRock, Inc. | 2025-Q4 | Increased | 8M | +5.3% | $371.9M | 0.0% | 33 |
| FARALLON CAPITAL MANAGEMENT LLC | 2025-Q4 | Increased | 6.9M | +20.2% | $322.7M | 1.5% | 58 |
Showing 5 of 124 results.PROUpgrade to see all → |
Upgrade to Pro for 2 years of historical data, full analytics access, and CSV exports
Starting at $16/mo billed annually